OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
35
Results
Show all
Save search
Copy query
Show results for
Unknown
(35)
Release Date
2024
(6)
2021
(5)
2023
(4)
2017
(4)
2022
(3)
2019
(3)
2018
(2)
2016
(2)
2025
(1)
2020
(1)
2015
(1)
2013
(1)
2010
(1)
2009
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Cytokine secretion profiling of human mesenchymal stem cells by antibody array.
Not available
S-EPMC4021795
|
biostudies-literature
Cite
Patient-Reported Outcomes in Patients With
PIK3CA
-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1.
Not available
S-EPMC8210974
|
biostudies-literature
Cite
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Not available
S-EPMC10618649
|
biostudies-literature
Cite
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study.
Not available
S-EPMC2892941
|
biostudies-literature
Cite
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer.
Not available
S-EPMC10986425
|
biostudies-literature
Cite
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.
Not available
S-EPMC10469654
|
biostudies-literature
Cite
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Not available
S-EPMC5106833
|
biostudies-literature
Cite
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Not available
S-EPMC11175669
|
biostudies-literature
Cite
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions.
Not available
S-EPMC10810713
|
biostudies-literature
Cite
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Not available
S-EPMC10837780
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
